SARS-CoV-2 (2019-nCoV) IgG/IgM Rapid Test Kit (CAT#: VCok-Wyb003)
CAT
Size
Price
Quantity
VCok-Wyb003
For Research Use Only. We do not provide direct services or products for patients.
Product Overview
The SARS-CoV-2 (2019-nCoV) IgG/IgM Rapid Test Kit is an immunochromatographic-based assay for the simultaneous detection of IgG and IgM antibodies to SARS-CoV-2 virus in human serum, plasma or whole blood. The assay can be used as an aid in the diagnosis of COVID-19.
Target
SARS-CoV-2
Specificity
IgG and IgM antibodies to SARS-CoV-2 virus
Contents
SARS-CoV-2 (2020-nCoV) IgG/IgM Test Card in foil pouch; Sample buffer.
Testing
SARS-CoV-2 IgG/IgM
Testing Principle
Immuno-chromatography
Sensitivity
93.10%
Applications
Aid in the diagnosis of COVID-19
Storage
Store at 4 - 30°C
Introduction
The 2019 novel coronavirus, or "SARS-CoV-2", was discovered because of Wuhan virus pneumonia cases in 2019, and was named by the World Health Organization on January 12, 2020. It belongs to the beta genera of the Coronaviridae family, together with SARS coronavirus in 2003 and MERS coronavirus in 2012. The alignment between SARS-CoV-2 and 2003 SARS CoV has about 70% sequence similarity and 40% sequence similarity with MERS CoV. The coronavirus genome encodes a spike protein, an envelope protein, a membrane protein, and a nucleoprotein. Among them, spike protein is the most important surface membrane protein of coronavirus.